Detalhe da pesquisa
1.
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Neurol
; 22(10): 890-899, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37739572
2.
Implementation of Motor Function Measure score percentile curves - Predicting motor function loss in Duchenne muscular dystrophy.
Eur J Paediatr Neurol
; 36: 78-83, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929615
3.
Health-related quality of life, self-reported impairments and activities of daily living in relation to muscle function in post-polio syndrome.
J Patient Rep Outcomes
; 4(1): 59, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676980
4.
Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
Trials
; 20(1): 637, 2019 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31752977
5.
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy.
J Vis Exp
; (143)2019 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30688316
6.
Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis.
Neuromuscul Disord
; 28(1): 16-23, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174526
7.
Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomised, placebo-controlled, double-blind trial.
Trials
; 18(1): 116, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28274276